WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CMPX

Based on 4 analysts offering 12 month price targets for Compass Therapeutics Inc.
Min Forecast
$8.00+154.78%
Avg Forecast
$9.33+196.97%
Max Forecast
$10.30+228.03%

Should I buy or sell CMPX stock?

Based on 4 analysts offering ratings for Compass Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMPX stock forecasts and price targets.

CMPX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 12%
89
BuyReiterates$10.00+218.47%2023-03-16
Jefferies
Bottom 11%
11
Strong BuyInitiates Coverage On$8.00+154.78%2023-01-31
Stifel Nicolaus
Bottom 6%
6
Strong BuyInitiates Coverage On$9.00+186.62%2023-01-27
EF Hutton
Top 16%
85
Strong BuyInitiates Coverage On$10.30+228.03%2022-12-16

1 of 1

Forecast return on equity

Is CMPX forecast to generate an efficient return?
Company
N/A
Industry
0.06%
Market
72.15%

Forecast return on assets

Is CMPX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.09%

CMPX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CMPX$3.14$9.33+196.97%Strong Buy
SIGA$5.58N/AN/A
AVTE$15.84$36.00+127.27%Strong Buy
ICVX$9.47$27.00+185.11%Buy
WVE$4.09$7.50+83.37%Buy
View Top Biotech Stocks

Compass Therapeutics Stock Forecast FAQ

Is Compass Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CMPX) stock is to Strong Buy CMPX stock.

Out of 4 analysts, 3 (75%) are recommending CMPX as a Strong Buy, 1 (25%) are recommending CMPX as a Buy, 0 (0%) are recommending CMPX as a Hold, 0 (0%) are recommending CMPX as a Sell, and 0 (0%) are recommending CMPX as a Strong Sell.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.

What is CMPX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CMPX) forecast ROE is N/A, which is considered weak.

What is CMPX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CMPX price target, the average CMPX price target is $9.33, with the highest CMPX stock price forecast at $10.30 and the lowest CMPX stock price forecast at $8.00.

On average, Wall Street analysts predict that Compass Therapeutics's share price could reach $9.33 by Mar 16, 2024. The average Compass Therapeutics stock price prediction forecasts a potential upside of 196.97% from the current CMPX share price of $3.14.

What is CMPX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CMPX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.